AxoGen, Inc. (AXGN) vs Establishment Labs Holdings Inc. (ESTA)
- AxoGen, Inc. AXGN 50.00 +2.56%
- Establishment Labs Holdings Inc. ESTA 66.77 +3.65%
AxoGen, Inc. and Establishment Labs Holdings Inc. are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.9B against $1.9B — 1.5× the size. Establishment Labs Holdings Inc. grew revenue faster over the last twelve months: 38.6% against 24.3%. AxoGen, Inc. has the higher net margin (−12.0% vs −15.8%) and the higher return on invested capital (−5.27% vs −5.53%). Across the 18 metrics below, AxoGen, Inc. leads on 12 and Establishment Labs Holdings Inc. on 6.
Valuation
Profitability
| Metric | AXGN | ESTA | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 70.49% | 57.76% |
| Operating margin | (5.17%) | (7.63%) | (15.07%) |
| Net margin | (11.96%) | (15.82%) | (14.45%) |
| Free cash flow margin | 7.50% | (16.90%) | (3.88%) |
| Return on equity | (10.35%) | (175.30%) | (10.35%) |
| Return on assets | (8.33%) | (11.41%) | (17.26%) |
| Return on invested capital | (5.27%) | (5.53%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack